Tulane University School of Medicine, New Orleans, Louisiana.
Loyola University Stritch School of Medicine, Chicago, Illinois.
J Hypertens. 2021 Jan;39(1):153-161. doi: 10.1097/HJH.0000000000002590.
The aim of this study was to determine the association of low antihypertensive medication adherence with decline in health-related quality of life (HRQOL) over 1 year.
We used data from older men and women with hypertension (n = 1525) enrolled in the Cohort Study of Medication Adherence among Older Adults. Adherence was measured using the validated self-report four-item Krousel-Wood Medication Adherence Scale (K-Wood-MAS-4) (low adherence = score ≥1) and prescription refill-based proportion of days covered (PDC) (low adherence = PDC < 0.80). We defined decline in HRQOL as a decrease in Mental Component Summary (MCS) or Physical Component Summary (PCS) score (from the RAND 36-Item Health Survey 1.0 administered at two time points - at the time of adherence assessment and 1 year later) equivalent to the minimal important difference (MID) for each respective summary score, calculated as the average of MID estimates derived from distribution and anchor-based approaches.
The prevalence of low adherence was 38.6% using the K-Wood-MAS-4 and 23.9% using PDC. On the basis of mean MID estimates of 4.40 for MCS and 5.16 for PCS, 21.8 and 25.2% of participants experienced a decline in MCS and PCS, respectively, over 1 year. Low adherence was associated with a decline in MCS for K-Wood-MAS-4 [prevalence ratio = 1.32, 95% confidence interval (95% CI) 1.08-1.62, P = 0.008], but not PDC (prevalence ratio = 1.17, 95% CI 0.94-1.47, P = 0.168). Low adherence was not associated with decline in PCS (K-Wood-MAS-4: prevalence ratio = 0.95, 95% CI 0.79-1.16; PDC: prevalence ratio = 1.10, 95% CI 0.90-1.35).
Low self-report medication adherence is associated with decline in mental HRQOL over 1 year in older adults with hypertension.
本研究旨在确定降压药物治疗依从性低与 1 年内健康相关生活质量(HRQOL)下降的关系。
我们使用了参加老年人药物治疗依从性队列研究的 1525 名高血压老年男女的数据。使用经过验证的自我报告四项 Krousel-Wood 药物依从性量表(K-Wood-MAS-4)(低依从性=得分≥1)和基于处方再填充的比例天数覆盖(PDC)(低依从性=PDC<0.80)来衡量依从性。我们将 HRQOL 的下降定义为心理成分综合得分(MCS)或生理成分综合得分(PCS)下降(从 RAND 36-Item Health Survey 1.0 在两个时间点进行评估-在依从性评估时和 1 年后),相当于每个综合得分的最小重要差异(MID),这是使用分布和基于锚定的方法得出的 MID 估计值的平均值。
使用 K-Wood-MAS-4 的低依从性发生率为 38.6%,使用 PDC 的低依从性发生率为 23.9%。根据 MCS 的平均 MID 估计值为 4.40,PCS 的平均 MID 估计值为 5.16,分别有 21.8%和 25.2%的参与者在 1 年内经历了 MCS 和 PCS 的下降。K-Wood-MAS-4 的低依从性与 MCS 的下降相关(患病率比=1.32,95%置信区间(95%CI)1.08-1.62,P=0.008),但 PDC 无相关性(患病率比=1.17,95%CI 0.94-1.47,P=0.168)。低依从性与 PCS 的下降无关(K-Wood-MAS-4:患病率比=0.95,95%CI 0.79-1.16;PDC:患病率比=1.10,95%CI 0.90-1.35)。
在高血压老年患者中,自我报告的药物治疗依从性低与 1 年内心理 HRQOL 下降有关。